Straits Times Index
3,314.14 +8.12 (+0.25%) S&P 500
5,464.62 -8.55 (-0.16%) Dow
39,150.33 +15.53 (+0.04%) Nasdaq
17,689.36 -32.24 (-0.18%) Bitcoin USD
60,991.88 -3,260.21 (-5.07%) CMC Crypto 200
1,260.86 -48.86 (-3.73%)
ACET Jun 2024 2.500 call
- Business Wire
Adicet Bio Announces FDA Clearance of IND Application for ADI-270 in Renal Cell Carcinoma
REDWOOD CITY, Calif. & BOSTON, June 24, 2024--Adicet Bio, Inc. (Nasdaq: ACET), a clinical stage biotechnology company discovering and developing allogeneic gamma delta T cell therapies for autoimmune diseases and cancer, today announced that the U.S. Food and Drug Administration (FDA) has cleared the Company’s Investigational New Drug (IND) application to evaluate ADI-270, an armored allogeneic "off-the-shelf" gamma delta chimeric antigen receptor (CAR) T cell therapy candidate targeting CD70+ c
- Insider Monkey
Is Adicet Bio, Inc. (NASDAQ:ACET) the Best Halal Stock ?
We recently compiled the list of the 7 Best Halal Stocks To Buy Now (Debt Free) according to the hedge funds using the latest sentiment data. In this article, we are going to take a look at where Adicet Bio, Inc. (NASDAQ:ACET) stands against the other halal debt free stocks. Halal Investing: Debt-Free Stocks, Islamic […]
- Simply Wall St.
We're Keeping An Eye On Adicet Bio's (NASDAQ:ACET) Cash Burn Rate
We can readily understand why investors are attracted to unprofitable companies. For example, biotech and mining...
